Information Technology
Bracco Imaging Achieves New Global Milestone with ANVISA Clearance of AiMIFY™ in Brazil
With ANVISA approval, Bracco is now working to make AiMIFY available to imaging providers across Brazil , enabling broader access to advanced diagnostic innovation in one of Latin America's most strategically important healthcare markets.
AiMIFY leverages advanced AI technology to amplify the contrast enhancement of brain MRI scans after administration of a labelled dose of Gadolinium-Based Contrast Agents (GBCAs) up to twice the initial value.
This provides radiologists with improved contrast information - particularly aiding in the visualization of small and poorly enhanced lesions. AiMIFY has demonstrated consistent performance across a wide range of validation data, including diverse patient demographics, pathologies, lesion sizes, scanner vendors, MRI sequences, and acquisition orientations.
said Sascha Daeuber , Global Radiology Platform Leader at Bracco Imaging.
said Tommaso Montemurno, General Manager for Latin America at Bracco Imaging
said Josh Gurewitz , Chief Commercial Officer at Subtle Medical.
AiMIFY is manufactured for Bracco Imaging S.p.A. by Subtle Medical Inc. – Menlo Park, CA , USA 94025.
AiMIFY is a trademark of Bracco Imaging S.p.A.
Bracco Imaging is a global leader in diagnostic imaging, dedicated to improving people's lives by shaping the future of prevention and precision medicine. With a strong passion for innovation, the company develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging: contrast agents for X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), as well microbubbles for Contrast Enhanced Ultrasound (CEUS), and Molecular Imaging through radioactive tracers and novel PET imaging agents, alongside specialized medical devices and related services.
The company is committed to advancing radiology by sharing knowledge to cultivate future thought leaders, linking today's practice with tomorrow's progress. Since 1927, Bracco Imaging has grown to more than 3,800 employees and now supports patients and radiology professionals in over 100 countries.
Discover Bracco Imaging at .
Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scan efficiency and image quality across radiology. Recognized as a CB Insights GenAI 50 company and twice named among the CB Insights Top AI 100 and Digital Health 150, Subtle Medical is dedicated to innovation in medical imaging. Deployed globally across 900+ scanners, our solutions help imaging centers and hospitals improve workflow efficiency, enhance scanner longevity, and elevate patient outcomes. Learn more and request a demo at .
Bracco Imaging, Communications Director
Logo - https://mma.prnewswire.com/media/2712101/Bracco_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/bracco-imaging-achieves-new-global-milestone-with-anvisa-clearance-of-aimify-in-brazil-302620772.html